The U.S. government is set to conclude its health assistance programs in Zimbabwe by the end of September. This decision follows Harare’s rejection of a new bilateral funding model, citing data privacy concerns. Over the past two decades, the U.S. has been a crucial supporter of Zimbabwean public health, including providing funding for antiretroviral drugs (ARVs) for HIV treatment and stipends for healthcare workers.
U.S. Ambassador Pamela Tremont stated that Zimbabwe has achieved HIV epidemic control, with over 95% of people living with HIV receiving treatment, and emphasized that sustaining these gains under local leadership remains the primary goal. The U.S. has updated its global health delivery model to a new Memorandum of Understanding (MOU) framework that requires co-investment from host nations. Following Zimbabwe’s rejection of this bilateral agreement, U.S.-funded health operations are slated to wrap up on September 30.
Key Players Involved
- U.S. Government: Announced the conclusion of health assistance programs.
- Zimbabwean Government: Rejected a new bilateral funding model citing data privacy concerns.
- U.S. Ambassador Pamela Tremont: Commented on Zimbabwe’s HIV epidemic control and the updated funding model.
Event Timeline
- September 23, 2026: News breaks regarding the U.S. decision to end health funding.
- September 30, 2026: U.S.-funded health operations in Zimbabwe are scheduled to conclude.
